Medical laboratory science
6.24K subscribers
907 photos
2 videos
1.68K files
527 links
Welcome to channel ๐Ÿค for
โ†—๏ธCOC question
โ†—๏ธDocument (ppt and reference)
โ†—๏ธ Vacancy for job
โ†—๏ธownerโ˜‘๏ธ @ymfkejela
โ†—๏ธGroup๐Ÿ‘‰ @laboratoryfree
โ†—๏ธ Channel๐Ÿ‘‰ @Laboratorypractice
โœ… youtube.com/@laboratorypractice
Download Telegram
Serology exam 2025
Mycology 2025 exam
๐Ÿ‘‡๐Ÿ‘‡๐Ÿ‘‡๐Ÿ‘‡๐Ÿ‘‡๐Ÿ‘‡
@laboratorypractice
โค3๐Ÿ‘2
๐Ÿฉธ Coagulation Pathways: Stopping the Bleeding! ๐Ÿฉน

Let's explore how your body forms blood clots to prevent excessive bleeding.

I. Overview: The Coagulation Cascade โš™๏ธ

โ€ข  Purpose: To form a stable fibrin clot at the site of injury.
โ€ข  Two Main Pathways: Intrinsic and Extrinsic pathways.
โ€ข  Convergence: Both pathways lead to a common pathway, ultimately activating Factor X.

II. Visual Aid: Simplified Coagulation Diagram ๐Ÿ–ผ๏ธ

   INTRINSIC PATHWAY                 EXTRINSIC PATHWAY

   (Starts Inside the Blood Vessel)          (Starts Outside the Blood Vessel)

  Factor XII --(Activated by Contact)--> XIIa     Tissue Factor (TF)
    |                         /  |
    |                         /  |
  Factor XI --> XIa                 /   |
    |                        /   |
  Factor IX --> IXa --(with Factor VIII, Ca++)-->  /    VII --> VIIa
    |                       /
    |                      /
    ------------------------- \          /
                 -----> Factor X -----> Common Pathway

   COMMON PATHWAY:

   Factor X --(with Factor V, Ca++, Platelet Surface)--> Xa

   Prothrombin --> Thrombin

   Fibrinogen --> Fibrin (Clot)

III. Intrinsic Pathway (Contact Activation Pathway): ๐Ÿฉธ

โ€ข  Trigger: Activated by contact with negatively charged surfaces inside the blood vessel (e.g., collagen, activated platelets, artificial surfaces).
โ€ข  Factors Involved: XII, XI, IX, VIII.
โ€ข  Process:
  โ€ข  Factor XII is activated to XIIa by contact.
  โ€ข  XIIa activates XI to XIa.
  โ€ข  XIa activates IX to IXa.
  โ€ข  IXa, along with Factor VIII, calcium ions (Ca++), and platelet phospholipids, forms a complex that activates Factor X.
โ€ข  Measured By: Activated Partial Thromboplastin Time (aPTT) lab test.โฑ๏ธ

IV. Extrinsic Pathway (Tissue Factor Pathway): ๐Ÿฉน

โ€ข  Trigger: Tissue Factor (TF) is released by damaged cells outside the blood vessel.
โ€ข  Factors Involved: Tissue Factor (TF), Factor VII.
โ€ข  Process:
  โ€ข  Tissue Factor (TF) binds to Factor VII, forming a complex.
  โ€ข  This TF-VIIa complex directly activates Factor X.
โ€ข  Measured By: Prothrombin Time (PT) lab test. โณ

V. Common Pathway: ๐Ÿ”„

โ€ข  Where the magic happens and to form to clot
โ€ข  Factors Involved: X, V, Prothrombin, Fibrinogen.
โ€ข  Process:
  โ€ข  Factor Xa, along with Factor V, calcium ions, and platelet phospholipids, forms the prothrombin activator complex.
  โ€ข  This complex converts prothrombin to thrombin.
  โ€ข  Thrombin converts fibrinogen to fibrin monomers, which then polymerize to form a fibrin clot.
  โ€ข  Factor XIIIa stabilizes the fibrin clot.

VI. Platelets in Coagulation: ๐Ÿฅ

โ€ข  Primary Hemostasis: Platelets adhere to the injured vessel wall, form a platelet plug.
โ€ข  Secondary Hemostasis: Platelets provide a surface for coagulation factors to bind and activate, accelerating clot formation.
โ€ข   Provide surface for the factor to work each other.

VII. Clinical Significance: ๐Ÿฉบ

โ€ข  Understanding the coagulation pathways is vital for:
  โ€ข  Diagnosing bleeding disorders (e.g., hemophilia). ๐Ÿฉธ
  โ€ข  Monitoring anticoagulant therapy (e.g., warfarin, heparin). ๐Ÿ’Š
  โ€ข  Investigating thrombotic disorders (e.g., deep vein thrombosis). ๐Ÿฆต
โค5๐Ÿ‘3โœ1๐Ÿ‘จโ€๐Ÿ’ป1
Medical laboratory science pinned ยซAll course for medical laboratory. (Tap on pinned message for get All course). ๐Ÿ‘‡๐Ÿ‘‡๐Ÿ‘‡๐Ÿ‘‡๐Ÿ‘‡๐Ÿ‘‡๐Ÿ‘‡๐Ÿ‘‡ยป
๐Ÿ“ฃ Greetings, Medical Lab Visionaries! ๐Ÿ”ฌ We're Building Something BIG! ๐Ÿš€

Hello, fellow members of @laboratorypractice! ๐Ÿ‘‹ I'm overjoyed to welcome you to a channel dedicated to building an even brighter future for Medical Laboratory Science (MLS) professionals right here in Ethiopia! ๐ŸŽ‰

We're on an exciting journey, and you're a vital part of it! This channel isn't just about exams or textbooks, but a path to a greater professional growth, helping the people know what the next step is. We're committed to profound professional development that will help us reach for our goals.

What's the Goal?

โ€ข  ๐Ÿš€ Elevate MLS in Ethiopia: Our mission is to help make you the same professional as any one in the world. ๐ŸŒ
โ€ข  ๐Ÿ“š Beyond the Books: We're going to dive deep into professional development.
โ€ข  ๐Ÿ’ก Knowledge Sharing: The place for a new generation of medical tech.
โ€ข  ๐Ÿค Build a Strong Community: Together, we can create an environment where the people are together.

What We'll Be Doing:

โ€ข  โญ Insider Tips & Resources: Exclusive content to help you.
โ€ข  ๐Ÿง  Cutting-Edge Insights: Stay updated on the latest.
โ€ข  ๐Ÿ’ฌ Connect & Collaborate: Discuss your experiences and expertise.

This is Your Channel!

I believe the key to our success is community. That is why I am here, to reach out. Please help us spread the word to make that success we want!

โ€ข  ๐Ÿ“ข Share the Link! Copy and share @laboratorypractice far and wide!
โ€ข  ๐Ÿค Invite Your Network! Invite your friends and people you now about who would like to be here.

We have big dreams for the future of MLS in Ethiopia. We want a better community for us to learn. So share and invite so we can make the community where people can see.

Letโ€™s help MLS grow for better.

Channel Link: @laboratorypractice

Thank you for being here and let's build this to the next level! ๐Ÿ’–
โค4๐Ÿ‘2โœ1
Medical laboratory science
1. Medical Parasitology Introduction.pptx
๐Ÿ‘†๐Ÿ‘†๐Ÿ‘†๐Ÿ‘†๐Ÿ‘†๐Ÿ‘†๐Ÿ‘†๐Ÿ‘†
Parasitology pdf
โค3
#MoE

แ‰ตแˆแˆ…แˆญแ‰ต แˆšแŠ’แˆตแ‰ดแˆญ แ‹จ2018 แ‰ตแˆแˆ…แˆญแ‰ต แ‹˜แˆ˜แŠ• แ‹จแŠจแแ‰ฐแŠ› แ‰ตแˆแˆ…แˆญแ‰ต แŠ แŠซแ‹ณแˆšแŠญ แŠซแˆ‹แŠ•แ‹ฐแˆญแŠ• แ‹ญแ‹ แŠ แ‹ตแˆญแŒ“แˆแกแก


แ‰ แ‰ตแˆแˆ…แˆญแ‰ต แˆšแŠ’แˆตแ‰ตแˆญ แ‹ฒแŠคแ‰ณ แŠฎแˆซ แŒกแˆนแŠ” แ‰ แ‰€แŠ• แАแˆแˆด 12/2017 แ‹“.แˆ แ‹จแ‰ฐแˆแˆจแˆ˜ แ‹จ2018 แ‰ตแˆแˆ…แˆญแ‰ต แ‹˜แˆ˜แŠ• แ‹จแŠจแแ‰ฐแŠ› แ‰ตแˆแˆ…แˆญแ‰ต แŠ แŠซแ‹ณแˆšแŠญ แŠซแˆ‹แŠ•แ‹ฐแˆญ แ‹แˆญแ‹แˆญ แˆˆแˆแˆ‰แˆ แŠจแแ‰ฐแŠ› แ‰ตแˆแˆ…แˆญแ‰ต แ‰ฐแ‰‹แˆ›แ‰ต แ‰ฐแˆแŠณแˆแกแก

แˆ˜แˆตแŠจแˆจแˆ 05-06/2018 แ‹“.แˆ
โžซ แ‹จแˆ˜แŒ€แˆ˜แˆชแ‹ซ แ‹“แˆ˜แ‰ต แ‹จแ‰…แ‹ตแˆ˜ แˆแˆจแ‰ƒ แ‰ฐแˆ›แˆชแ‹Žแ‰ฝ (แˆชแˆšแ‹ฒแ‹ซแˆ แ‰ฐแˆ›แˆชแ‹Žแ‰ฝแŠ• แŒจแˆแˆฎ) แ‰ แ‹จแ‰ฐแˆ˜แ‹ฐแ‰กแ‰ แ‰ต แ‹ฉแŠ’แ‰จแˆญแˆฒแ‰ฒ แˆชแ–แˆญแ‰ต แ‹ซแ‹ฐแˆญแŒ‹แˆ‰แกแก

แˆ˜แˆตแŠจแˆจแˆ 08-09/2018 แ‹“.แˆ
โžซ
แ‹จแˆแˆ‰แˆ แ‹จแ‰…แ‹ตแˆ˜ แŠฅแŠ“ แ‹จแ‹ตแŠ…แˆจ แˆแˆจแ‰ƒ แˆ˜แ‹ฐแ‰ แŠ› แŠฅแŠ“ แŠข-แˆ˜แ‹ฐแ‰ แŠ› แ‰ฐแˆ›แˆชแ‹Žแ‰ฝ (แˆชแˆšแ‹ฒแ‹ซแˆ แ‰ฐแˆ›แˆชแ‹Žแ‰ฝแŠ• แŒจแˆแˆฎ) แˆแ‹แŒˆแ‰ฃ แ‹ซแ‹ฐแˆญแŒ‹แˆ‰แกแก

แˆ˜แˆตแŠจแˆจแˆ 12/2018 แ‹“.แˆ
โžซ
แ‹จแˆแˆ‰แˆ แ‹จแ‰…แ‹ตแˆ˜ แŠฅแŠ“ แ‹จแ‹ตแŠ…แˆจ แˆแˆจแ‰ƒ แˆ˜แ‹ฐแ‰ แŠ› แŠฅแŠ“ แŠข-แˆ˜แ‹ฐแ‰ แŠ› แ‰ฐแˆ›แˆชแ‹Žแ‰ฝ แ‰ แ‰…แŒฃแ‰ต แˆแ‹แŒˆแ‰ฃแฃ
โžซ แ‹จ2018 แ‹“.แˆ แ‹จแˆ˜แŒ€แˆ˜แˆชแ‹ซ แˆดแˆšแˆตแ‰ฐแˆญ แ‰ตแˆแˆ…แˆญแ‰ต แ‹ญแŒ€แˆ˜แˆซแˆแกแก

(แˆ™แˆ‰ แ‹จ2018 แ‰ตแˆแˆ…แˆญแ‰ต แ‹˜แˆ˜แŠ• แ‹จแŠจแแ‰ฐแŠ› แ‰ตแˆแˆ…แˆญแ‰ต แŠ แŠซแ‹ณแˆšแŠญ แŠซแˆ‹แŠ•แ‹ฐแˆญ แŠจแˆ‹แ‹ญ แ‰ฐแ‹ซแ‹ญแ‹Ÿแˆแกแก)
๐Ÿ‘‡๐Ÿ‘‡๐Ÿ‘‡๐Ÿ‘‡๐Ÿ‘‡๐Ÿ‘‡
@Laboratorypractice
  @Laboratorypractice
โค3๐Ÿ‘1
แˆˆ ๐—›๐—œ๐—š๐—›๐—ฆ๐—–๐—›๐—ข๐—ข๐—Ÿ แ‰ฐแˆ›แˆชแ‹Žแ‰ฝ แˆ˜แˆแŠซแˆ แ‹œแŠ“

แˆ˜แƒแแ‰ต แ‹จแˆแ‰ณแŒˆแŠ™แ‰ แ‰ตแŠ• แˆแˆญแŒฅ แ‰ปแŠ“แˆŽแ‰ฝ แˆแŒ‹แ‰ฅแ‹›แ‰น แ‰ตแ‹ˆแ‹ณแˆ‹แ‰นแข
Old group gatii ajaibanin bitaa jira harra carraa kanatti fayyadamaa

Today  we buy old group by highest price so use this chance. 

๐Ÿ‘‰2016-2021 โ†—๏ธ 1050 birr
๐Ÿ‘‰2022           โ†—๏ธ 1000birr
๐Ÿ‘‰2023           โ†—๏ธ 900birr
๐Ÿ‘‰2024
     ๐Ÿ‘‰  Janu.    โ†—๏ธ   600birr
      ๐Ÿ‘‰    Februarโ†—๏ธ   600
      ๐Ÿ‘‰    March.  โ†—๏ธ  300 birr
      ๐Ÿ‘‰   April     โ†—๏ธ   100 birr
       ๐Ÿ‘‰  May.     โ†—๏ธ   50 birr
        ๐Ÿ‘‰   June    โ†—๏ธ 10 birr
     
           Inbox @Yer_tech
                      @Yer_tech
                       @Yer_tech

Channel @laboratorypractice

               Other ๐Ÿ‘‡๐Ÿ‘‡
               @web_technology1
                @web_technology1
๐Ÿ‘3โค1
The Sabin-Feldman dye test


is a serological test used to detect antibodies against Toxoplasma gondii, the parasite that causes toxoplasmosis. It was one of the original tests for toxoplasmosis and is still considered a reference test in some laboratories, although it is less commonly used today due to its complexity and the need for live parasites.

Here's an overview of the Sabin-Feldman dye test procedure:

Principle:

The test is based on the principle that viable Toxoplasma tachyzoites (the rapidly multiplying form of the parasite) can take up a dye (methylene blue) in the absence of specific antibodies. However, if specific antibodies are present in the patient's serum, they will interact with the tachyzoites, causing them to become "neutralized" and unable to take up the dye.

Materials:

โ€ข  Live Toxoplasma tachyzoites: This is the most critical and challenging aspect of the test, as it requires a source of viable parasites. They are typically maintained in cell culture.
โ€ข  Methylene blue dye: A dye that is taken up by viable tachyzoites.
โ€ข  Test serum: The patient's serum, which is serially diluted.
โ€ข  Complement: Fresh, unheated serum from a source that provides complement (e.g., normal human serum or rabbit serum). Complement is required for the antibody-mediated neutralization of the tachyzoites.
โ€ข  Microscope slides and coverslips: For viewing the tachyzoites.
โ€ข  Microscope: A light microscope for examining the slides.
โ€ข  Diluent: Phosphate-buffered saline (PBS) or a similar buffer.

Procedure:

1. Tachyzoite Preparation:
  โ€ข  Harvest live Toxoplasma tachyzoites from cell culture.
  โ€ข  Wash the tachyzoites to remove cell debris.
  โ€ข  Adjust the concentration of tachyzoites to the desired level (typically around 10^6 tachyzoites/mL).

2. Serum Dilutions:
  โ€ข  Prepare serial dilutions of the patient's serum in the diluent (e.g., 1:16, 1:64, 1:256, etc.).
  โ€ข  Include a positive control (serum known to contain Toxoplasma antibodies) and a negative control (serum known to be antibody-free).

3. Test Mixture:
  โ€ข  Mix equal volumes of the diluted serum, the Toxoplasma tachyzoite suspension, and the complement source.
  โ€ข  Incubate the mixture at 37ยฐC for 1 hour to allow the antibody-complement interaction to occur.

4. Dye Addition:
  โ€ข  Add methylene blue dye to each mixture.
  โ€ข  Incubate for a few minutes.

5. Slide Preparation:
  โ€ข  Place a drop of each mixture onto a microscope slide.
  โ€ข  Cover with a coverslip.

6. Microscopic Examination:
  โ€ข  Examine the slides under a light microscope at a magnification of 400x or higher.
  โ€ข  Count the number of stained (blue) and unstained (clear) tachyzoites in each field of view.
  โ€ข  Examine at least 100 tachyzoites per slide.

Interpretation:

โ€ข  Positive Result: If the serum contains Toxoplasma antibodies, the tachyzoites will be neutralized and will not take up the methylene blue dye. Therefore, a positive result is indicated by a high percentage of unstained (clear) tachyzoites. A titer is determined as the highest dilution of serum that results in at least 50% unstained tachyzoites.
โ€ข  Negative Result: If the serum does not contain Toxoplasma antibodies, the tachyzoites will remain viable and will take up the methylene blue dye. Therefore, a negative result is indicated by a high percentage of stained (blue) tachyzoites.

Quality Control:

โ€ข  Positive Control: Should show a high percentage of unstained tachyzoites.
โ€ข  Negative Control: Should show a high percentage of stained tachyzoites.
โ€ข  Complement Control: A control mixture containing tachyzoites and complement, but no serum, should show a high percentage of stained tachyzoites. This ensures that the complement is not toxic to the tachyzoites.
โ€ข  Tachyzoite Viability: The tachyzoites should be actively motile and of good quality.
Limitations

โ€ข  Subjective Interpretation: The interpretation of the results is somewhat subjective and depends on the experience of the observer.

๐Ÿ‘‡๐Ÿ‘‡๐Ÿ‘‡๐Ÿ‘‡๐Ÿ‘‡๐Ÿ‘‡
@Laboratorypractice
@laboratorypractice
โค3
โš ๏ธ Widal Test: Diagnosing Typhoid Fever ๐Ÿฆ 

Understanding this important serological test used to detect Typhoid Fever

I. What is Typhoid Fever? ๐Ÿค”

โ€ข  Cause: Caused by Salmonella typhi bacteria. ๐Ÿฆ 
โ€ข  Transmission: Spread through contaminated food or water. ๐Ÿ•๐Ÿ’ง
โ€ข  Symptoms: Fever, headache, abdominal pain, constipation or diarrhea. ๐Ÿค• ๐ŸŒก๏ธ ๐Ÿ’ฉ

II. What is the Widal Test? ๐Ÿงช

โ€ข  Type: A serological test (detects antibodies in the blood). ๐Ÿฉธ
โ€ข  Purpose: Used to help diagnose typhoid fever by detecting antibodies against Salmonella typhi antigens. ๐ŸŽฏ
โ€ข  Principle: The test detects antibodies (specifically, "O" and "H" antigens) produced by the body in response to a Salmonella typhi infection. ๐Ÿ›ก๏ธ
โ€ข  Agglutination: The test relies on agglutination (clumping) of the antibodies and antigens. ๐Ÿฆ +๐Ÿ›ก๏ธ = ๐Ÿงฑ

III. How is the Test Performed? โš™๏ธ

โ€ข  Sample: Blood sample is collected from the patient. ๐Ÿ’‰
โ€ข  Serial Dilutions: The serum is diluted in a series of tubes. ๐Ÿ’ง
โ€ข  Antigen Addition: Specific Salmonella typhi antigens (O and H) are added to each dilution. ๐Ÿฆ 
โ€ข  Observation: The tubes are observed for agglutination (clumping). ๐Ÿ‘€
โ€ข  Titer: The highest dilution showing agglutination is reported as the titer. ๐Ÿ“ˆ

IV. Interpretation of Results: ๐Ÿ“Š

โ€ข  Positive Result: Significant agglutination at a specific titer suggests a Salmonella typhi infection. ๐Ÿ‘
โ€ข  Rising Titer: A rising titer in paired samples taken a few days apart is more indicative of recent infection. โฌ†๏ธ
โ€ข  Limitations:
  โ€ข  False positives can occur due to past exposure or vaccination. โš ๏ธ
  โ€ข  False negatives can occur early in the infection (before antibodies develop). โš ๏ธ
  โ€ข  The Widal test has lower sensitivity and specificity compared to other diagnostic methods (e.g., blood culture).

V. Important Notes: ๐Ÿ“

โ€ข  Gold Standard: Blood culture remains the gold standard for diagnosing typhoid fever. ๐Ÿฅ‡
โ€ข  Clinical Correlation: Widal test results must be interpreted in conjunction with clinical symptoms and other lab findings. ๐Ÿฉบ
โ€ข  Consultation: A physician should be consulted for proper diagnosis and treatment. ๐Ÿ‘จโ€โš•๏ธ

Share this important information with your colleagues! Follow @laboratorypractice for more essential lab insights! ๐Ÿ”ฌ
โค2๐Ÿ‘1